Mutant-specific pharmacological inhibition of KRAS in multiple myeloma and functional genomics studies to identify mechanisms regulating myeloma cell response vs. resistance to KRAS inhibition

被引：0
|
作者：
Steinbrunn, Torsten [1 ,2 ,3 ,4 ]
Shirasaki, Ryosuke [1 ,2 ,3 ,5 ,6 ]
Dashevsky, Olga [1 ,2 ,3 ]
Tang, Huihui [1 ,2 ,3 ,5 ]
Yamano, Shizuka [1 ,2 ]
Teoh, Phaik Ju [1 ,2 ,3 ,7 ,8 ]
Leypoldt, Lisa [1 ,2 ,3 ,9 ]
Sugihara, Takeru [1 ,2 ,3 ]
Mizuno, Rin [1 ,2 ,3 ]
Kaji, Mariko [1 ]
Sorrell, Jeffrey [1 ,2 ]
Glassner, Brian [1 ,2 ,3 ]
Simoes, Ricardo de Matos [1 ,2 ,3 ]
Christensen, James [10 ]
Mitsiades, Constantine [1 ,2 ,3 ,5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Massachusetts Inst Technol MIT & Harvard, Broad Inst, Cambridge, MA USA
[4] Univ Hosp Wurzburg, Dept Med 2, Wurzburg, Germany
[5] Harvard Med Sch, Ludwig Ctr, Boston, MA 02115 USA
[6] Teikyo Univ Med, Dept Hematol Oncol, Tokyo, Japan
[7] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[8] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore
[9] Univ Med Ctr Hamburg Eppendorf, Dept Hematol Oncol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany
[10] Mirati Therapeut Inc, San Diego, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-371
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 12 条
  • [1] CRISPR-Based Functional Genomics Studies Identify Mechanisms of Multiple Myeloma (MM) Cell Response to vs. Resistance Against Novel Pharmacological Mutant-Specific KRAS Inhibitors
    Steinbrunn, Torsten
    Shirasaki, Ryosuke
    Dashevsky, Olga
    Tang, Huihui
    Yamano, Shizuka
    Teoh, Phaik Ju
    Leypoldt, Lisa
    Mizuno, Rin
    Glassner, Brian
    Simoes, Ricardo de Matos
    Christensen, James
    Mitsiades, Constantine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S180 - S181
  • [2] Targeting Mutant KRAS with Novel Mutant-Specific Pharmacological Inhibitors: Activity Against Myeloma and Other Lymphoid Malignant Cells and Molecular Mechanisms of Resistance
    Steinbrunn, Torsten
    Shirasaki, Ryosuke
    Dashevsky, Olga
    Tang, Huihui
    Yamano, Shizuka
    Mizuno, Rin
    Sugihara, Takeru
    Teoh, Phaik Ju
    Leypoldt, Lisa B.
    Kaji, Mariko
    Sorrell, Jeffrey
    Glassner, Brian J.
    Simoes, Ricardo De Matos
    Christensen, James
    Mitsiades, Constantine S.
    BLOOD, 2023, 142
  • [3] Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma
    Qiang, Ya-Wei
    Ye, Shiqiao
    Chen, Yu
    Epstein, Joshua
    Davies, Faith E.
    Morgan, Gareth
    Walker, Brian A.
    van Rhee, Frits
    BLOOD, 2019, 134
  • [4] Mutant KRAS and Brafs Upregulate Stress Granules and Mediate Drug Resistance, Which Can be Modulated By Cox2 Inhibition in Multiple Myeloma
    Qiang, Ya-Wei
    Ye, Shiqiao
    Chen, Yu
    Epstein, Joshua
    Walker, Brian A.
    van Rhee, Frits
    Morgan, Gareth
    Davies, Faith E.
    BLOOD, 2018, 132
  • [5] Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer
    Araujo, Haniel A.
    Pechuan-Jorge, Ximo
    Zhou, Teng
    Do, Minh Truong
    Hu, Xin
    Alvarez, Frank R. Rojas
    Salvatierra, Maria E.
    Ibarguen, Heladio P.
    Lee, Richard
    Raghulan, Rashi
    Shah, Harshit
    Ayala, Mariela A. Moreno
    Chen, Kevin
    Shifrin, Nataliya Tovbis
    Wu, Shuhong
    Soto, Luisa M. Solis
    Negrao, Marcelo V.
    Gibbons, Don L.
    Hong, David S.
    Roth, Jack A.
    Heymach, John V.
    Zhang, Jianjun
    Jiang, Jingjing
    Singh, Mallika
    Smith, Jacqueline A. M.
    Quintana, Elsa
    Skoulidis, Ferdinandos
    CANCER DISCOVERY, 2024, 14 (11) : 2183 - 2208
  • [6] Overcoming Cell Subtype-Specific Adaptive Resistance to KRAS G12D Inhibition in KRAS G12D-Mutant Pancreatic Cancer
    Lin, Qingxiang
    Morales, Alvin
    Barnes, Haley
    Corcoran, Ryan Bruce
    CANCER RESEARCH, 2024, 84 (17)
  • [7] Inhibition of multiple myeloma-derived exosomes uptake suppresses the functional response in bone marrow stromal cell
    Zheng, Yongjiang
    Tu, Chenggong
    Zhang, Jingwen
    Wang, Jinheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (03) : 1061 - 1070
  • [8] Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
    Cecilia Bandini
    Elisabetta Mereu
    Tina Paradzik
    Maria Labrador
    Monica Maccagno
    Michela Cumerlato
    Federico Oreglia
    Lorenzo Prever
    Veronica Manicardi
    Elisa Taiana
    Domenica Ronchetti
    Mattia D’Agostino
    Francesca Gay
    Alessandra Larocca
    Lenka Besse
    Giorgio Roberto Merlo
    Emilio Hirsch
    Alessia Ciarrocchi
    Giorgio Inghirami
    Antonino Neri
    Roberto Piva
    Experimental Hematology & Oncology, 12
  • [9] Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
    Bandini, Cecilia
    Mereu, Elisabetta
    Paradzik, Tina
    Labrador, Maria
    Maccagno, Monica
    Cumerlato, Michela
    Oreglia, Federico
    Prever, Lorenzo
    Manicardi, Veronica
    Taiana, Elisa
    Ronchetti, Domenica
    D'Agostino, Mattia
    Gay, Francesca
    Larocca, Alessandra
    Besse, Lenka
    Merlo, Giorgio Roberto
    Hirsch, Emilio
    Ciarrocchi, Alessia
    Inghirami, Giorgio
    Neri, Antonino
    Piva, Roberto
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [10] Activity-based protein profiling reveals adaptive response to pharmacological MEK inhibition in KRAS mutant non-small cell lung cancer
    Kim, Jae-Young
    Fang, Bin
    Welsh, Eric A.
    Kinose, Fumi
    Li, Jiannong
    Eschrich, Steven A.
    Koomen, John M.
    Haura, Eric B.
    MOLECULAR CANCER RESEARCH, 2014, 12
12